News & Updates

Ablating the gastric fundus to reduce the production of the hunger hormone ghrelin helps women curb their appetite and lose body weight in the ABLATE-WEIGHT first-in-human trial.

In patients with stage II colon cancer, individuals with a right-sided colon cancer (RSCC) appear to have a better prognosis than those with a left-sided colon cancer (LSCC), reveals a recent study. Additionally, adjuvant chemotherapy (ACT) falls short of improving cause-specific survival (CSS) in patients with either RSCC or LSCC.

In the prespecified interim analysis of the phase III ALIGN study, the investigational drug atrasentan shows promising signals when added to standard supportive care with a renin-angiotensin system (RAS) inhibitor in patients with IgA nephropathy (IgAN).

On 16 April 2024, GSK organised the Trelegy Asthma: Release From Constriction seminar in Singapore. The event featured talks from distinguished experts, Associate Professor Loo Chian Min and Professor Simon Bowler who provided insights on the disease burden of asthma in Singapore and how a precision medicine approach with the single-inhaler triple therapy, Trelegy Ellipta, can improve lung function and symptom control in patients with uncontrolled asthma. The session was chaired by Dr Kenneth Chan.

Increased practice of Chinese calligraphy strengthens brain network in older individuals who already practice the cognitive activity regularly and experienced subjective cognitive decline (SCD), a two-arm, parallel-design, assessor-blind, randomized controlled trial conducted by the Chinese University of Hong Kong (CUHK) has found.

Glucose-lowering drugs such as the glucagon-like peptide-1 receptor agonist (GLP-1-RA), sodium-glucose cotransporter 2 inhibitor (SGLT2i), and dipeptidyl peptidase-4 inhibitor (DPP-4i) work better and are more cost-effective than sulfonylureas and glinides (SU) as second-line treatment for type 2 diabetes (T2D), according to a population-based retrospective cohort study.

People born in 1965 or later show signs of accelerated ageing, a phenomenon that is potentially related to the rising incidence of early-onset solid tumours worldwide, according to a large study.